Z-Link Sponsors Binod Tamang for His Airtel Delhi Half Marathon and Schooling (November 21, 2016)
Binod is 22-year-old student from a small village in Kalimpong district in India. Through Ms. Roshni Rai, one of the fellow runners in this year’s Everest Marathon, Dr. Tan learned the amazing story of Run with Roshni Foundation and Binod.  Both Roshni and Binod are India Gorkhas. The Foundation’s goal is to help elimination of identity crisis faced by India Gorkhas through supporting Gorkha runners.  Despite suffering from stomachache, Binod finished the race in 1 Hour 17 min that put him in the 8th position. 
https://www.facebook.com/notes/run-with-roshni/airtel-delhi-half-marathon-2016-binod-tamang/1345874935476460

Nominations are open for Animal Pharm Awards and Dr. Tan as member of the judging panel (November 30, 2016)
The Animal Pharm Awards for 2016 are open for nominations until December 16, 2016. The awards are designed to honor achievements within the animal health sector over the calendar year. Subscribers can nominate companies, products and employees for any of the 12 accolades.  If you are a subscriber of Animal Pharm and interested in the nomination, please click
NOMINATIONnow. The nominations are then collated and then sent to the judging panel. Dr. Tan is honored to be selected as member of the judging panel.

The twelve Animal Pharm Award categories are: Best R&D Pipeline award, Best Product Portfolio award, Best New Product – Food Animals award, Best New Product – Companion Animals award, Best Start-up award, Best company – India/Africa/Middle East, Best company – Europe, Best company – North America, Best company – Latin & South America, Best company – Asia and Australasia, Best contract research organization, and Visionary CEO.

“Holding your hand in partnership while you navigate through

the Chinese business process.”

Z-Link Biotech is flying hight in Nepal​​  (May 31, 2016)

Dr. Tan participated in the 2016 Tenzing-Hillary Everest Marathon -  the highest marathon and the most adventurous trail run in the world. The journey began on May 20 with a spectacular helicopter scenic flight from Kathmandu to Lukla then Namche Bazaar. Then the group trekked through Sherpa villages with beautiful view of the world's highest snowcapped peaks. The highest spot of this trip was Kalapatthar at 5545m/18200ft where a breathtaking panoramic view of Himalayan peaks could be seen (photo above).
On May 29, the marathon started from the Everest Base Camp (5364m/17,598ft) and finishes at Namche Bazaar (3446m/11306ft). The measured distance of the course was 42.195 km (26.2 miles) over rough mountain trails.
This amazing event was conducted to commemorate the first successful ascent of Everest by Late Tenzing Norgay Sherpa and Late Sir Edmund Hillary on 29th May, 1953. 
http://www.everestmarathon.com/

Linking  Science and Business

Animal Health Investment Asia Forum held in Hong Kong on Oct 19 – 20, 2016 was a big success!  (October 21, 2016)
This two-day event was organized by Kisaco Research, following on from their first successful European Animal Health Investment Forum held in London earlier this year. The forum provides an international investment and business development platform to bring new emerging technologies, financial investors and multinational corporations together with regional players in China and other countries in the Asia-Pacific region.
 A number of keynote speakers from leading global and regional animal health companies and organizations shared their insightful views on animal health market opportunities and challenges. Twelve emerging companies, carefully selected by a group of industry experts, presented the innovations and opportunities they had to offer to various kinds of business partnerships, including technology transfer, capital investment and M&A opportunities.
There were approximately 150 participants in attendance, representing animal health industry leaders, financial investors and service providers. A unique feature of the Animal Health Investment Forum is the one on one meetings between companies to explore partnership opportunities. Hundreds of these meetings were tightly scheduled over a 36-hour period.
Dr. Tan chaired one of the Emerging Company sessions and also introduced Z-Link Biotech to the audience. Despite being a new service company, Z-Link Biotech has already secured several contracts. Current clients include the Bill & Melinda Gates Foundation, GALVmed, Phagelux, Pacific Gene Tech, and three Chinese animal health companies and research organizations.

(The next Animal Health Investment Forum: Animal Health Investment Europe 22nd-23rd February, 2017, http://animalhealthevent.com/)

Animal Health Investment Asia to be held in Hong Kong  (April 28, 2016)

Dr. Tan is honorably invited to be member of the Selection Committee and Speaker Faculty for ​Animal Health Investment Asia.  Animal Health Investment Asia is a global industry forum designed as a neutral business networking and partnership platform on which senior executives from leading multinational firms can leverage as both a meeting place and a marketplace. It will be held October 19th and 20th 2016 in Hong Kong. For more information please visit http://animalhealthasia.com/


Veterinary Biological Forum attracted over 200 participants  (October 30, 2016)

The forum was held in conjunction with the 7th China (Taizhou) International Medical Expo 2016 on October 29, 2016 in the China Medical Park, Taizhou city, Jiangsu province. It was organized by China Medical Park, Sinovet, Zhongchong Sino Biopharmaceutical, and Boehringer Ingelheim. Representatives from 19 universities and research institutes, and over 50 Chinese and international animal vaccine companies were present. Dr. Tan as one of the keynote speakers gave a presentation on “Animal Health Industry: Development & Strategy”.Type your paragraph here.

学商

Dr. Tan attended two conferences in China in February and March(March 2, 2017)
Dr. Tan was the invited speaker in two national conferences. The first one was an investment forum organized by Zhongtai Securities held on February 16 in Hangzhou. Dr. Tan’s presentation was “The Animal Health Industry – from both Global and Chinese Perspectives”. Both animal health companies and investors attended the meeting. Long-term prospect of animal health business is good. It is anticipated that Chinese animal health industry will grow at 6% - 8% per year. The second conference was the International Symposium on Health of Aquatic Animals and Nutrition Immunology held on March 1 – 2 in Guangzhou. It was organized by Animal Nutrition and Feed Committee of Chinese Fishery Society and sponsored by Guangdong Hinabiotech Co. Ltd. As one of the twelve invited speakers, Dr. Tan presented “Health Management for Aquaculture – Prevention is More Important Than Cure”. China is by far the leading aquaculture country in the world, accounting over 60% of world production. Nevertheless the industry is facing many issues including threads of diseases. Improvement on health management is the must for sustainability. To request a copy of the presentation, please email
tan@zlinkbiotech.com​

Z-Link Biotech partners visiting SinoVet in Taizhou  (April 21, 2016)

Dr. Tan and Dr. Guan visited SinoVet's Taizhou biological manufacturing facility on April 19 - 21, 2016.
SinoVet is a research-based animal vaccine company. In the last few years, they developed a number of innovative animal vaccines, including the world's first attenuated live PRRS and CSF bivalent vaccine for swine.

Z-Link Biotech and SinoVet will collaborate to further develop vaccine and related technology.

Animal Health Innovation Asia to be held in Beijing (July 1, 2017)​​
Z-Link is proud to be Event Partner of ANIMAL HEALTH INNOVATION ASIA, a forum to be held in Beijing on October 18 & 19. The summit's objectives are to gather the industry leader to discuss the topics of partnership and cooperation opportunities in China market. The forums’ session is including one-on-one private meetings, educational lecture, topical meetings, and advancing topical lecture provided by the wider international leader and CEO.  Within this two-days’ time being, it is a unique opportunity that providing you to meet the partnerships on M&A and investment, and usually this process will take several months to achieve.

On Day 1, Dr. Tan will host a SPECIAL SESSION WITH CHINESE LEADERSHIP with interesting subjects such as:
• Future prospect of Chinese animal health market and needs of innovation
• The presence of multinational companies in China, strategy of market entry and best practice
• Opportunity for domestic and international companies working together
• Progress on animal health R&D in China
• Strategy of outbound investment for Chinese companies
Speakers will include leading leaders from Chinese animal health companies. They are Dr. Tingwu Xue, President, CHINA ANIMAL HUSBANDRY GROUP (CAHG), Dr. Yongsheng Wang, General Manager, JINYU GROUP, Dr. Shoujun Norman Li, CEO, TIANJIN RINGPU and Dr. Ruiai Chen, President, WEN’S DAHUANONG

Click here to download the agenda

​​​​​Z-Link Biotech Co. Ltd.

​​​​​Z-Link Biotech is a service and support company with a focus on animal health and animal biotechnology. Our key team members are based in China and the U.S.A. and have extensive expertise across various therapeutic areas throughout the product life-cycle, from product R&D to commercialization. We aim to provide quality tailor-made services to:
1) Chinese companies who are seeking advanced technology and export opportunities, and
2) International companies who want to enter the growing Chinese market and/or improve market penetration.​​

Applications open for the Brucellosis vaccine prize & Z-Link as coordinator for Chinese applicants ​(November 20, 2016)
The Brucellosis Vaccine Prize, a US $30 million prize competition, invites vaccine developers ("Solvers") to submit their proposals for - and ultimately develop - a suitable vaccine that is efficacious, safe and viable for use against Brucella melitensis in small ruminants across the developing world.  Applications for Phase 1 open until November 18, 2017. Animal health, biotech and pharmaceutical companies and other organizations are invited to submit their proposals through
http://www.brucellosisvaccine.org/
Z-Link Biotech is honored to be selected as contracted agent for coordinating applications from Chinese organizations. 

读中西

Z-Link Biotech- Animal Health for China

Animal Health Innovation Asia: Market Access and Investment In Beijing, China (Oct 18-19, 2017)

News & Announcements

 Z-Link Biotech is born​  (March 29, 2016)

Z-Link Biotech was established in March 29, 2016. Our registered office is in Hong Kong.  China is the second largest and fastest growing animal health market in the world. Chinese companies are looking for partnerships with Western companies to address a variety of unmet needs. Z-Link Biotech is committed to providing quality service and support to organizations involved in R&D and commercialization of animal health products.

  Linking  East and  West

​​​​​易联生物科技有限公司 

China is the focus of Animal Health Innovation Asia this year.  The industrial leaders of wider animal health will come together to discuss in term of innovation, strategic partnerships and business opportunities in the region. Z-Link Biotech is proud to be a Partner of event and Dr. Tony Zilong Tan will be a speaker of panelist.


• Hear ten strategic partners from China present their innovations in livestock and companion animal health at the Company Showcase
• Join a special session with Chinese Leadership to ask questions face-to-face and to see how global organisations can benefit from building relationships in China
• Visit two Chinese facilities to see how vaccine research, vaccine development and product registration testing and approval are conducted in China
• Gain a wealth of valuable contacts, with 18+ hours of dedicated partnering time on-site Book now to get valuable market access insights into this part of the world


Dr Tony Zilong Tan :   30+ years of animal health industry experience:

- Management roles in R&D, regulatory affairs, manufacturing, marketing, sales, and business development.

- Extensive international business experience and has worked in the USA, Europe and Asia (particularly in China).